{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:22:52Z","timestamp":1790400172200,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T00:00:00Z","timestamp":1284681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s10549-010-1165-8","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T01:20:39Z","timestamp":1284600039000},"page":"885-891","source":"Crossref","is-referenced-by-count":18,"title":["Two novel variants in the 3\u2032UTR of the BRCA1 gene in familial breast and\/or ovarian cancer"],"prefix":"10.1007","volume":"125","author":[{"given":"St\u00e9phanie","family":"Lheureux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Legros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Vaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Denoyelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascaline","family":"Berthet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Poulain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Hardouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,17]]},"reference":[{"key":"1165_CR1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66\u201371","journal-title":"Science"},{"key":"1165_CR2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789\u2013792","journal-title":"Nature"},{"key":"1165_CR3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329\u20131333","journal-title":"J Clin Oncol"},{"key":"1165_CR4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMcp071286","volume":"357","author":"M Robson","year":"2007","unstructured":"Robson M, Offit K (2007) Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med 357:154\u2013162","journal-title":"N Engl J Med"},{"key":"1165_CR5","doi-asserted-by":"crossref","unstructured":"Hennessy BT, Timms KM, Carey MS, Gutin A, Meyer LA, Flake DD, Abkevich V, Potter J, Pruss D, Glenn P, Li Y, Li J, Gonzalez-Angulo AM, McCune KS, Markman M, Broaddus RR, Lanchbury JS, Lu KH, Mills GB (2010) Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly(ADP ribose) polymerase inhibitors in ovarian cancer. J Clin Oncol 28:3570\u20133576","DOI":"10.1200\/JCO.2009.27.2997"},{"key":"1165_CR6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(10)60893-8","volume":"376","author":"MW Audeh","year":"2010","unstructured":"Audeh MW, Carmichael J, Penson RT, Friedlander M, Powell B, Bell-McGuinn KM, Scott C, Weitzel JN, Oaknin A, Loman N, Lu K, Schmutzler RK, Matulonis U, Wickens M, Tutt A (2010) Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet 376:245\u2013251","journal-title":"Lancet"},{"key":"1165_CR7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(10)60892-6","volume":"376","author":"A Tutt","year":"2010","unstructured":"Tutt A, Robson M, Garber JE, Domchek SM, Audeh MW, Weitzel JN, Friedlander M, Arun B, Loman N, Schmutzler RK, Wardley A, Mitchell G, Earl H, Wickens M, Carmichael J (2010) Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet 376:235\u2013244","journal-title":"Lancet"},{"key":"1165_CR8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676\u2013689","journal-title":"Am J Hum Genet"},{"key":"1165_CR9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc2054","volume":"7","author":"JD Fackenthal","year":"2007","unstructured":"Fackenthal JD, Olopade OI (2007) Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 7:937\u2013948","journal-title":"Nat Rev Cancer"},{"key":"1165_CR10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tig.2007.02.011","volume":"23","author":"TW Nilsen","year":"2007","unstructured":"Nilsen TW (2007) Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet 23:243\u2013249","journal-title":"Trends Genet"},{"key":"1165_CR11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ijc.25065","volume":"127","author":"T Kontorovich","year":"2010","unstructured":"Kontorovich T, Levy A, Korostishevsky M, Nir U, Friedman E (2010) Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast\/ovarian cancer risk modifiers in Jewish high-risk women. Int J Cancer 127:589\u2013597","journal-title":"Int J Cancer"},{"key":"1165_CR12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/gtmb.2008.0127","volume":"13","author":"M Pongsavee","year":"2009","unstructured":"Pongsavee M, Yamkamon V, Dakeng S, Charoenrat P, Smith DR, Saunders GF, Patmasiriwat P (2009) The BRCA1 3\u2032-UTR: 5711+421T\/T_5711+1286T\/T genotype is a possible breast and ovarian cancer risk factor. Genet Test Mol Biomarkers 13:307\u2013317","journal-title":"Genet Test Mol Biomarkers"},{"key":"1165_CR13","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1158\/0008-5472.CAN-09-3541","volume":"70","author":"MS Nicoloso","year":"2010","unstructured":"Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, Manoukian S, Secreto G, Ravagnani F, Wang X, Radice P, Croce CM, Davuluri RV, Calin GA (2010) Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res 70:2789\u20132798","journal-title":"Cancer Res"},{"key":"1165_CR14","first-page":"455","volume":"59","author":"N Puget","year":"1999","unstructured":"Puget N, Stoppa-Lyonnet D, Sinilnikova OM, Pages S, Lynch HT, Lenoir GM, Mazoyer S (1999) Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res 59:455\u2013461","journal-title":"Cancer Res"},{"key":"1165_CR15","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1101\/gad.10.14.1835","volume":"10","author":"CY Liu","year":"1996","unstructured":"Liu CY, Flesken-Nikitin A, Li S, Zeng Y, Lee WH (1996) Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev 10:1835\u20131843","journal-title":"Genes Dev"},{"key":"1165_CR16","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/nar\/18.7.1687","volume":"18","author":"A Meyerhans","year":"1990","unstructured":"Meyerhans A, Vartanian JP, Wain-Hobson S (1990) DNA recombination during PCR. Nucleic Acids Res 18:1687\u20131691","journal-title":"Nucleic Acids Res"},{"key":"1165_CR17","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/nar\/26.7.1819","volume":"26","author":"MS Judo","year":"1998","unstructured":"Judo MS, Wedel AB, Wilson C (1998) Stimulation and suppression of PCR-mediated recombination. Nucleic Acids Res 26:1819\u20131825","journal-title":"Nucleic Acids Res"},{"key":"1165_CR18","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/ijc.24008","volume":"124","author":"J Shen","year":"2009","unstructured":"Shen J, Ambrosone CB, Zhao H (2009) Novel genetic variants in microRNA genes and familial breast cancer. Int J Cancer 124:1178\u20131182","journal-title":"Int J Cancer"},{"key":"1165_CR19","doi-asserted-by":"crossref","unstructured":"Gao LB, Bai P, Pan XM, Jia J, Li LJ, Liang WB, Tang M, Zhang LS, Wei YG, Zhang L (2010) The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. doi: 10.1007\/s10549-010-0993-x","DOI":"10.1007\/s10549-010-0993-x"},{"key":"1165_CR20","doi-asserted-by":"crossref","first-page":"E1052","DOI":"10.1002\/humu.21141","volume":"31","author":"I Catucci","year":"2010","unstructured":"Catucci I, Yang R, Verderio P, Pizzamiglio S, Heesen L, Hemminki K, Sutter C, Wappenschmidt B, Dick M, Arnold N, Bugert P, Niederacher D, Meindl A, Schmutzler RK, Bartram CC, Ficarazzi F, Tizzoni L, Zaffaroni D, Manoukian S, Barile M, Pierotti MA, Radice P, Burwinkel B, Peterlongo P (2010) Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat 31:E1052\u2013E1057","journal-title":"Hum Mutat"},{"key":"1165_CR21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00439-008-0529-1","volume":"124","author":"PM Campeau","year":"2008","unstructured":"Campeau PM, Foulkes WD, Tischkowitz MD (2008) Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet 124:31\u201342","journal-title":"Hum Genet"},{"key":"1165_CR22","doi-asserted-by":"crossref","first-page":"12629","DOI":"10.1073\/pnas.1007983107","volume":"107","author":"T Walsh","year":"2010","unstructured":"Walsh T, Lee MK, Casadei S, Thornton AM, Stray SM, Pennil C, Nord AS, Mandell JB, Swisher EM, King MC (2010) Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci USA 107:12629\u201312633","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1165-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-1165-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1165-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T16:35:22Z","timestamp":1559666122000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-1165-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,17]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["1165"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-1165-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,17]]}}}